Prognostic significance of dickkopf-1 overexpression in solid tumors: A meta-analysis

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3145-3154

  Liu, Yanqiong ^a   Tang, Weizhong ^a   Xie, Li ^a   Wang, Jian ^a   Deng, Yan ^a   Peng, Qiliu ^a   Zhai, Limin ^a   Li, Shan ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Dickkopf 1; Prognosis; Solid tumors; Survival; Tumor marker

Indexed keywords

DICKKOPF 1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; COLORECTAL CANCER; DISEASE FREE SURVIVAL; ESOPHAGUS CARCINOMA; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; STOMACH CANCER; TRANSITIONAL CELL CARCINOMA;

DISEASE-FREE SURVIVAL; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; PROGNOSIS; PUBLICATION BIAS;

EID: 84898797250     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1411-x     Document Type: Article

References (40)

1. Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R. Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int. 2013;2013:783131.
2. Zhang CH, Xu GL, Jia WD, Ge YS, Li JS, Ma JL, et al. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis. Int J Cancer J Int Du Cancer. 2012;130:2685-92.
3. Jiang JW, Liang XH, Zhou XL, Huang RF, Chu ZH, Zhan Q. Ercc1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis. Mol Biol Rep. 2012;39:6933-42.
4. Yang H, Chen B. Cd147 in ovarian and other cancers. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2013;23:2-8.
5. Ma X, Liu L, Nie W, Li Y, Zhang B, Zhang J, et al. Prognostic role of caveolin in breast cancer: a meta-analysis. Breast. 2013;22:462-9.
6. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391:357-62.
7. Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, et al. Dkk1, a negative regulator of wnt signaling, is a target of the beta-catenin/tcf pathway. Oncogene. 2004;23:8520-6.
8. Sato N, Yamabuki T, Takano A, Koinuma J, Aragaki M, Masuda K, et al. Wnt inhibitor dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010;70:5326-36.
9. Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, Martin J, et al. The wnt pathway regulator dkk1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer. 2007;96:646-53.
10. Jiang T, Huang L, Zhang S. Dkk-1 in serum as a clinical and prognostic factor in patients with cervical cancer. Int J Biol Markers. 2013;28:e221-5.
11. Gao C, Xie R, Ren C, Yang X. Dickkopf-1 expression is a novel prognostic marker for gastric cancer. J Biomed Biotechnol. 2012;2012:804592.
12. Hall CL, Daignault SD, Shah RB, Pienta KJ, Keller ET. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate. 2008;68:1396-404.
13. Yang H, Chen GD, Fang F, Liu Z, Lau SH, Zhang JF, Lau WY, Yang LY: Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma. The International journal of biological markers 2013:0.
14. Tao YM, Liu Z, Liu HL. Dickkopf-1 (dkk1) promotes invasion and metastasis of hepatocellular carcinoma. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2013;45:251-7.
15. Lee HS, Lee HE, Park Do J, Kim HH, Kim WH, Park KU. Clinical significance of serum and tissue dickkopf-1 levels in patients with gastric cancer. Clinica chimica acta. Int J Clin Chem. 2012;413:1753-60.
16. Wang S, Zhang S. Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion. Clin Exp Metastasis. 2011;28:581-91.
17. Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, et al. Elevated expression of dkk1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol. 2009;50:948-57.
18. Shizhuo W, Tao J, Shulan Z, Bing Z. The expression and significance of dickkopf-1 in epithelial ovarian carcinoma. Int J Biol Markers. 2009;24:165-70.
19. Sheng SL, Huang G, Yu B, Qin WX. Clinical significance and prognostic value of serum dickkopf-1 concentrations in patients with lung cancer. Clin Chem. 2009;55:1656-64.
20. Makino T, Yamasaki M, Takemasa I, Takeno A, Nakamura Y, Miyata H, et al. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16:2058-64.
21. Yamabuki T, Takano A, Hayama S, Ishikawa N, Kato T, Miyamoto M, et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res. 2007;67:2517-25.
22. Xu WH. Liu ZB, Yang C, Qin W, Shao ZM: Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype. PLoS One. 2012;7:e37624.
23. Tung EK, Mak CK, Fatima S, Lo RC, Zhao H, Zhang C, et al. Clinicopathological and prognostic significance of serum and tissue dickkopf-1 levels in human hepatocellular carcinoma. Liver Int Off J Int Assoc Study Liver. 2011;31:1494-504.
24. Shen CH, Hsieh HY, Wang YH, Chen SY, Tung CL, Wu JD, et al. High dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma. Exp Ther Med. 2010;1:893-8.
25. Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ, Liu C, et al. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. J Pathol. 2010;220:475-89.
26. Pozzi S, Fulciniti M, Yan H, Vallet S, Eda H, Patel K, et al. In vivo and in vitro effects of a novel anti-dkk1 neutralizing antibody in multiple myeloma. Bone. 2013;53:487-96.
27. Fulciniti M, Tassone P, Hideshima T, Vallet S, Nanjappa P, Ettenberg SA, et al. Anti-dkk1 mab (bhq880) as a potential therapeutic agent for multiple myeloma. Blood. 2009;114:371-9.
28. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA: J Am Med Assoc. 2000;283:2008-12.
29. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The newcastle-ottawa scale (nos) for assessing the quality of nonrandomized studies in meta-analyses.
30. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-34.
31. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327:557-60.
33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
34. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
35. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7:889-94.
36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
37. Egger M. Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997;315:629-34.
38. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-63.
39. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24.
40. Gonzalex-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, et al. The wnt antagonist dickkopf-1 gene is a downstream target of beta-catenin/tcf and is downregulated in human colon cancer. Oncogene. 2005;24:1098-103.